UK Cosmetic Procedures Face Landmark Regulation Overhaul as Experts Warn of Patient Safety Risks

The British Medical Journal has highlighted substantive patient safety concerns surrounding cosmetic interventions, warning that tighter regulation, consistent standards and stronger advertising controls are essential to safeguard patients in what has historically been described as a largely unregulated sector. This call comes as the UK government implements significant regulatory changes designed to bring order to an industry that has expanded rapidly without adequate oversight.

Cosmetic procedures—ranging from Botox injections and dermal fillers to more invasive body contouring treatments—have become increasingly accessible to the general public over recent years. However, the ease of access has raised alarm amongst medical professionals and regulators about patient safety, inadequate training standards amongst practitioners, and misleading advertising claims that may encourage unsuitable candidates to pursue treatment.

The Department of Health and Social Care’s response to a prolonged consultation, published in August 2025, sets out a comprehensive plan to regulate non-surgical cosmetic procedures across England. The centrepiece is a national licensing scheme enabled by Section 180 of the Health and Care Act 2022. Once secondary legislation is laid before Parliament, this will create a risk-based regulatory structure for the first time.

Cosmetic procedures will be categorised by risk level: red (highest risk), amber and medium-risk procedures, and green (lowest risk) treatments. High-risk invasive procedures such as significant body contouring will be restricted to regulated healthcare professionals working in Care Quality Commission (CQC) registered premises. Under the proposed framework, routine treatments including Botox and dermal fillers would require local authority licences for both practitioners and the businesses offering them. These licensing requirements have not yet come into force and await secondary legislation.

All licensed practitioners will need to demonstrate minimum standards for training, qualifications, hygiene, insurance and safety compliance. Botulinum toxin and dermal fillers for cosmetic purposes have already been banned for under-18s since October 2021 under the Botulinum Toxin and Cosmetic Fillers (Children) Act 2021. The proposed regulations would extend this principle to all licensed procedures.

Whilst the full licensing framework is being rolled out in phases throughout 2026, one key change took effect in 2025. All prescribing of prescription-only medicines—including botulinum toxin—must now be preceded by mandatory face-to-face consultations with prescribing clinicians. Remote prescribing without an in-person consultation is no longer compliant, a move designed to ensure patients receive proper assessment and informed consent before treatment.

Additionally, cosmetic clinics must now obtain explicit written consent from patients that clearly lists risks, alternatives and expected outcomes. Before-and-after images used in marketing must have patient consent and carry clear labelling. Patient records must document treatment plans, aftercare instructions and any adverse events—requirements that bring cosmetic settings closer in line with standard clinical governance expected in NHS facilities.

The absence of consistent regulation has allowed poorly trained individuals to administer invasive procedures with minimal oversight. The rise in cosmetic interventions, particularly amongst younger age groups influenced by social media, has coincided with an increase in complications including infection, allergic reactions, vascular injury and severe tissue damage. Without consistent standards for training, infection control and practitioner competency, patients have had little protection against substandard care.

The Advertising Standards Authority is also strengthening enforcement against misleading marketing claims that overstate benefits or downplay risks. Medical professionals have stressed that cosmetic procedures carry genuine health risks and should not be trivialised in advertising or presented as risk-free.

The regulatory changes are being introduced in phases. High-risk procedures move first, followed by amber and green categories as regulation structures become available. The government aims to phase in regulations from 2026, with a further public consultation expected in early 2026 and secondary legislation still required before licensing can begin. Industry observers note that the timeline may extend beyond 2027.

Clinics failing to comply face enforcement action and financial penalties. The message from regulators is clear: the “Wild West” era of cosmetic procedures is ending.

These regulatory developments mean that patients seeking cosmetic treatment will have stronger legal protections. Licensed practitioners will need to demonstrate proper training. Clinics will need to maintain detailed records and report serious incidents. Advertising claims will face scrutiny. Importantly, patients will have a right to clear information about risks, benefits and alternatives before making any decision.

Under the proposed framework, the Care Quality Commission would be responsible for inspecting and licensing premises offering high-risk (red category) procedures only. Lower-risk treatments would be licensed by local authorities. Professional bodies such as the Joint Council for Cosmetic Practitioners will continue to set higher standards beyond the baseline regulatory requirements.

Key Takeaways

• The UK government is introducing a national licensing scheme for non-surgical cosmetic procedures in 2026, categorising treatments by risk level and establishing minimum standards for training, qualifications and safety compliance.

• Under the proposed framework, all practitioners offering routine treatments such as Botox and dermal fillers will need to obtain local authority licences, whilst high-risk procedures are restricted to regulated healthcare professionals in registered premises.

• Mandatory face-to-face consultations before prescribing, enhanced written consent procedures and stricter advertising controls are already in force or being rolled out, designed to protect patients and reduce harm from poorly regulated treatments.

What This Means for Kent Residents

Kent residents seeking cosmetic treatment should now expect practitioners to hold appropriate local authority licences and to conduct thorough face-to-face consultations before proceeding. If you are considering cosmetic procedures, ask your practitioner about their qualifications, training accreditation and insurance. Check whether the clinic is registered with the Care Quality Commission—this registration ensures it meets mandatory safety standards. For concerns about cosmetic treatment, contact your GP. To report an unlicensed or unsafe practitioner, contact Kent County Council or Medway Council trading standards. If you have experienced harm from a cosmetic procedure, you can raise complaints with the Care Quality Commission or check the Save Face register — an NHS-accredited directory of safe practitioners.